What AHV International does

AHV International B.V. is a Dutch animal health company that develops proprietary complementary feed products and structured health programs for livestock, with primary focus on dairy cows and secondary exposure to swine and poultry. The company's core technology is AHV QSI (Quorum Sensing Inhibition), a patented approach that modulates bacterial communication rather than eradicating bacteria, enabling antibiotic-reducing interventions across the dairy production cycle (dry-off, udder health, transition, energy/metabolism, uterine health/fertility, calves, claw/skin/hygiene). Its product portfolio consists of oral tablet-based solutions (StopLac, Booster, StartLac, Aspi, Extra, Quick, CirQ Support, Metri) and topical support products (CirQ) administered through defined protocols, backed by peer-reviewed data showing up to 64.3% reduction in antibiotic use, 8,653 kg increases in lifetime milk production, and 19.8% reduction in herd replacement rates.

The business model is sales-led, monetized through direct-to-farmer sale of products via a global network of trained regional farm consultants/advisors who design farm-specific health plans, supplemented by a self-service e-commerce web shop at store.ahvint.com. The company operates through 15+ country-level offices covering 17+ markets across Europe (headquarters in Zwolle, Netherlands; plus Germany, UK/Ireland, France, Italy, Spain, Denmark, Poland, Hungary, Croatia, Slovenia, Serbia, Romania, Czechia), North America (Hilmar, California), South America (Chile), and Oceania (New Zealand). AHV holds feed-industry certifications including GMP+, SecureFeed, VLOG (non-GMO), and EU Feed Hygiene Regulation (EC) 183/2005 compliance, and OMRI-listing for organic operations in the US. As of April 30, 2026, the company was acquired by Elanco Animal Health (NYSE: ELAN) and now operates as a subsidiary within Elanco's global farm animal health franchise.

Name

AHV International

Legal name

AHV International B.V.

Website

https://ahvint.com

Company type

Private

Founded year

2014

Operating status

Acquired

Headcount range

251–500 employees

Short description

AHV International is a Dutch animal health company developing patented Quorum Sensing Inhibition (QSI) feed supplements and protocols for dairy, swine, and poultry farmers, distributed through regional consultant networks across 17+ countries and now an Elanco Animal Health subsidiary.

Ownership category

akta.pro rank

Product category

Animal Health and Veterinary Nutrition

NAICS

Animal Food Manufacturing (3111)

SIC

Agricultural Prod-Livestock & Animal Specialties (200), Agricultural Services (700)

akta.pro primary industry

Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support) (AFADALAO)

akta.pro secondary industries

Livestock & Poultry Nutrition (Feed & Premixes) (HLAMAHAD), Animal Nutrition & Feeding Support Services (On-Farm Feeding, Feed Management) (AFAEALAJ), Performance & Health Outcome Consulting (growth, FCR, milk yield, gut health) (AFADAMAG)

Keywords

• Animal health products
• Dairy cattle nutrition
• Quorum sensing inhibition
• Udder health solutions
• Antibiotic reduction feeds

Headquarters

HQ city

Augher

HQ country

United Kingdom

HQ region

Europe

Offices15 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Animal Health Products: AHV develops and sells innovative animal health solutions primarily for dairy cows, with additional offerings for swine and poultry. Products are sold through a network of farm consultants/advisors and distributed directly to farmers. The company focuses on sustainable, antibiotic-reducing solutions.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

AHV International develops and sells proprietary complementary animal feed products (tablets, pastes, and boluses) based on its patented Quorum Sensing Inhibition (QSI) technology for dairy cows, swine, and poultry. Its portfolio is delivered through structured health programs such as the Dry-Off Program and Udder Health Program, supported by a global network of farm consultants who advise farmers on product selection, implementation, and follow-up. Products are registered under feed hygiene regulations and positioned as sustainable, antibiotic-reducing alternatives.

Product overview

AHV International offers a comprehensive portfolio of animal health products organized into three segments: Dairy Cows & Calves, Swine, and Poultry. The core product line centers on tablet-based solutions (StopLac, Booster, StartLac, Aspi, Extra, Quick, CirQ Support, Metri) that are administered through structured health programs and protocols. These programs are designed to support animals during critical stages including dry-off, transition periods, and calving, with a focus on udder health, energy metabolism, uterine health, and calf rearing. The company positions its products as natural alternatives that reduce antibiotic dependence while improving herd longevity and productivity.

Differentiator

Problem solved

Functional benefit

Products and services

• StopLac Tablet

Quantifiable outcome

• Up to 64.3% reduction in antibiotics use based on trials across 39 farms including 6,874 cows
• +3 more outcomes

Named customers11 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Elanco Animal HealthcoreStrategic or Co-development Partner · 30 April 2026AHV International was acquired by Elanco Animal Health on April 30, 2026. This acquisition brings together two organizations with a common commitment to advancing the health of food animals worldwide. The acquisition deepens Elanco's presence in dairy farm animal health across North America and Europe, allowing better service to the growing global dairy industry.

Scale indicators1 record

Expansion highlights6 records

Direct peers

• Bio-Vet: Specialty animal nutrition company offering direct-fed microbials, boluses, and nutritional supplements for dairy and beef cattle. Closely comparable to AHV's tablet-based, on-farm administered product format for transition and udder health.
• Alltech: Privately-held global leader in animal nutrition and feed supplements for dairy, beef, swine, and poultry. Direct competitor to AHV in on-farm nutritional solutions, feed additives, and antibiotic-reduction programs for ruminants.

Broad incumbents

• Elanco Animal Health: Global animal health major (NYSE: ELAN) and acquirer of AHV. Overlaps with AHV in dairy cattle health, ruminant nutrition, and farm advisory services, and now serves as AHV's commercial platform following the April 2026 acquisition.
• DeLaval: Global dairy-focused equipment, automation, and advisory company supplying milking systems, farm management software, and consumables to dairy producers. Comparable in its dairy-exclusive advisory-led GTM and farm consultant model, though focused on equipment rather than nutrition.
• MSD Animal Health (Merck): Division of Merck offering a broad portfolio of animal pharmaceuticals, vaccines, and health management solutions for livestock and companion animals. Competes with AHV across dairy health, fertility, and antimicrobial stewardship programs.
• Ceva Santé Animale: Global animal health company offering vaccines, pharmaceuticals, and farm management solutions for ruminants, swine, and poultry. Directly comparable to AHV's advisory-plus-protocol model for dairy and swine producers.
• Phibro Animal Health: Public animal health and nutrition company focused on livestock productivity, including dairy nutritional specialty products, vaccines, and mineral nutrition. Closely comparable business model to AHV in performance and nutritional health for dairy producers.
• Zoetis: World's largest pure-play animal health company, offering pharmaceuticals, vaccines, diagnostics, and nutrition across dairy, beef, swine, and poultry. Competes with AHV for the dairy producer wallet, especially in udder health, transition cow management, and reproductive health.
• Boehringer Ingelheim Animal Health: Top-3 global animal health player with strong presence in dairy, swine, and poultry vaccines and therapeutics. Overlaps with AHV in udder health, transition management, and on-farm advisory services for ruminant and swine producers.

Emerging players

• Kemin Industries: Privately-held ingredient manufacturer with a strong animal nutrition and health division supplying feed additives, gut-health solutions, and antibiotic-replacement technologies to livestock producers globally. Comparable in targeting antibiotic reduction and gut/immune health in dairy and poultry.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/ahvint

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AHV International